Stock fact sheet · data as of

Concord Medical Services Holdings Limited (CCM): fair value, margin of safety and Wheel Score

Healthcare · Medical - Care Facilities · China · ADR · Speculative / Distressed

Close3.62
GLS fair value-no model value
Margin of safety-
Wheel Score34No optionscapped: no options
Health6/9Piotroski F-score
Moat1.3/10GLS 10-year score
Market cap$524K8k shares a day
Implied vol.-no listed options
P/E-EPS -114.57
Dividend yieldnone
Beta-0.94moves less than the market
Next earnings-no date recorded

Is CCM undervalued?

At 3.62 (close of 16 Oct 2026), CCM has no GLS fair value: every one of the nine models needs a positive input (the company lost money over the last twelve months, EPS -114.57, it pays no dividend and its debts exceed what its assets would fetch), so the margin of safety is blank and the Wheel Score cannot be computed. Our screens leave the stock out at the first rule. What can be said from the nightly row is below.

The nightly engine files CCM under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for CCM

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)-25,948.23-716902%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Concord Medical Services Holdings Limited scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 1.3/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC -6.1%, ROE 4.4%, ROA -1.4% - with debt at -1.73 times equity and negative free cash flow.

Concord Medical Services Holdings Limited pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Services and other revenues 81%, Medicine income 17%, Equipment Leasing Revenues 2% (fiscal year FY2025).

Institutional ownership scores 1/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score6 / 9ROIC-6.1%
GLS Moat1.3 / 10ROE4.4%
Debt / equity-1.73ROA-1.4%
Free-cash-flow yield0.0%Payout ratio0%
Institutions1 / 10Insiders · Congress5 · 5 / 10

Wheel Score 34: No options

No options are listed on Concord Medical Services Holdings Limited in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 34) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 8k shares a day on a market cap of $524K, with a beta of -0.94 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.

PartPointsFrom
Value13 / 250% margin of safety
Health13 / 20Piotroski 6/9
Moat2 / 15moat 1.3/10
Premium0 / 20no option data
Stability6 / 208k shares/day, $1M cap, beta -0.94

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for CCM in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Care Facilities

The 12 companies below are the closest to Concord Medical Services Holdings Limited by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
FOXO
FOXO Technologies Inc.
0.11000.8043+86%39No options$1M
PMHS
Polomar Health Services, Inc.
0.12500.0935-34%17No options$4M
AIDX
20/20 Biolabs Inc.
0.2751--30No options$4M
RHEP
Regional Health Properties, Inc.
1.0231,975.90+100%39No options$4M
BMGL
Basel Medical Group Ltd Ordinary Shares
3.91--30No options$6M
HLYK
HealthLynked Corp.
2.20--25No options$6M
BICX
BioCorRx Inc.
0.2500--28No options$7M
AMS
American Shared Hospital Services
1.266.91+82%39No options$8M
SYRA
Syra Health Corp. Class A Common Stock
0.84300.2255-274%14No options$10M
MNDR
Mobile-health Network Solutions Class A Ordinary Shares
1.09--33No options$27K
RHEPB
Regional Health Properties, Inc.
6.2539,547.42+100%39No options$11M
PIII
P3 Health Partners Inc.
4.37--24No options$14M

⚖ Compare CCM with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about CCM

Is CCM undervalued right now?

The GLS models could not value CCM (the company lost money over the last twelve months, EPS -114.57, it pays no dividend and its debts exceed what its assets would fetch), so there is no fair value or margin of safety to compare the price of 3.62 against.

What is the Wheel Score of CCM and what does it mean?

CCM has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for CCM?

None of the nine GLS models produced a positive value for CCM (the company lost money over the last twelve months, EPS -114.57, it pays no dividend and its debts exceed what its assets would fetch), so there is no GLS fair value tonight.

When does Concord Medical Services Holdings Limited report earnings next?

No upcoming earnings date is recorded for CCM in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does CCM have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on CCM, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.